Mark Walport Explained

Honorific Prefix:Sir
Mark Walport
Birth Name:Mark Jeremy Walport
Birth Date:1953 1, df=yes
Birth Place:London, England
Fields:Immunology
Rheumatology
Education:St Paul's School, London
Alma Mater:University of Cambridge (PhD)
Doctoral Advisor:Peter Lachmann[1]
Thesis Title:The biology of complement receptors
Thesis Year:1986
Thesis Url:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.383309
Children:one son, three daughters

Sir Mark Jeremy Walport (born 25 January 1953) is an English medical scientist and was the Government Chief Scientific Adviser in the United Kingdom from 2013 to 2017[2] [3] [4] [5] [6] [7] and Chief Executive of UK Research and Innovation (UKRI) from 2017 to 2020.[8] In 2023 he became the Foreign Secretary of The Royal Society (jointly with Alison Noble).[9]

Education

Walport is the son of a general practitioner and was born in London. He was educated at St Paul's School, London, studied medicine at Clare College, Cambridge, and completed his clinical training at Hammersmith, Guy's and Brompton Hospitals in London.[10] [11] He was awarded a PhD for research into complement receptors under the supervision of Peter Lachmann in 1986 at the University of Cambridge.[12]

Career and research

Previously Walport was Director of the Wellcome Trust from 2003 to 2013.[13] Before this, he was Professor of Medicine (from 1991) and Head of the Division of Medicine (from 1997) at Imperial College London,[10] where he led a research team that focused on the immunology and genetics of rheumatic diseases.[14] [15] [16] [17] [18] [19] [20] [21]

Walport was the eleventh Government Chief Scientific Adviser from 2013 to 2017, succeeding Sir John Beddington.

It was announced in February 2017 that Mark Walport is now Chief Executive of UK Research and Innovation (UKRI).[22]

Honours and awards

Walport was knighted in the 2009 New Year Honours list for services to medical research. He was elected an Honorary Fellow of the Royal Society of Edinburgh (FRSE) in 2017[23] and a Fellow of the Royal Society (FRS) in 2011.[24] [10] His nomination for the Royal Society reads:

Notes and References

  1. News: Wellcome to a new beginning. Tanya. Reed. Reporter: The newspaper of Imperial College London. 11 July 2003. 131.
  2. Callaway . Ewen . Britain names next chief science adviser: Immunologist Mark Walport, head of one of the world's largest biomedical charities, will take on role in 2013.. 10.1038/487020a . 22763530 . Nature . 487 . 7405 . 20 . 2012 . free .
  3. Mayor . S.. 10.1136/bmj.e4621. Mark Walport will be next UK government chief scientific adviser, cabinet office announces. BMJ. 345. e4621. 2012. 22767620. 11529948.
  4. Kain . K. H.. Funding scientific discovery: An interview with Sir Mark Walport. 10.1242/dmm.005710. Disease Models & Mechanisms. 3. 5–6. 265–267. 2010. 20427555. free.
  5. Anon. 10.1038/487005b . 22763508 . Good advice: The UK government's latest appointment offers hope for British science. . Nature . 487 . 7405 . 5–6 . 2012 . free .
  6. News: New chief scientific adviser announced . Times Higher Education. 29 June 2012. Elizabeth. Gibney.
  7. 10.1016/S0140-6736(11)60647-8. 21571134. Science as a public enterprise: The case for open data. The Lancet. 377. 9778. 1633–1635. 2011. Boulton . G. . Rawlins . M. . Vallance . P. . Walport . M. . 3048048.
  8. Web site: Dominic Cummings' science obsession: based on fact or fiction?. 2019-10-16. Times Higher Education (THE). en. 2019-11-25.
  9. Web site: Council . The Royal Society . 4 July 2023.
  10. Web site: Dr Sir Mark Walport. Debrett's. 14 February 2012.
  11. Morris . K.. Mark Walport. 10.1016/S0140-6736(03)14090-1. The Lancet. 362. 9382. 498–499. 2003. 12927451. 10861093.
  12. PhD. Mark Jeremy. Walport. The biology of complement receptors. University of Cambridge. 1986. . 59761908.
  13. Vogel . Gretchen. United Kingdom: Mark Walport to Take Reins at Wellcome Trust. 10.1126/science.299.5608.803a. Science. 299. 5608. 803a–. 2003. 12574591. 70581694. free.
  14. Web site: Mark Walport, PhD, MB. BChir., Member, Scientific Board. Grand Challenges in Global Health. 14 February 2012. dead. https://web.archive.org/web/20130927213531/http://www.grandchallenges.org/about/scientificboard/Pages/Walport.aspx. 27 September 2013. dmy-all.
  15. Walport . M.. Mark Walport. Foulkes . I.. Weissberg . P.. Morgan . D.. Nebhrajani . S.. Medical research: No catch to UK charity funding. 10.1038/482308a. Nature. 482. 7385. 308. 2012. 22337042. 2012Natur.482..308W. free.
  16. Collins . P. Y.. Patel . V.. Joestl . S. S.. March . D.. Insel . T. R.. Daar . A. S.. Scientific Advisory Board the Executive Committee of the Grand Challenges on Global Mental Health. Bordin . I. A.. Anderson . E. J.. Dhansay . M.. Phillips . C.. Shurin . R. I.. Walport . W.. Ewart . Y.. Savill . S. E.. Bordin . K.. Costello . S.. Durkin . S.. Fairburn . A.. Glass . A.. Hall . A.. Huang . M. M.. Hyman . V.. Jamison . B. J.. Kaaya . S.. Kapur . P. A.. Kleinman . D. J.. Ogunniyi . W.. Otero-Ojeda . M. A.. Poo . W.. Ravindranath . A.. Grand challenges in global mental health. Nature. 475. 7354. 27–30. 2011. 21734685. 3173804. 10.1038/475027a.
  17. Yamada . T.. Dautry . A.. Walport . M.. Mark Walport. 10.1038/454162a. Ready for avian flu?. Nature. 454. 7201. 162. 2008. 18615064. 2008Natur.454..162Y. 205039550. free.
  18. Pickering . M. C.. Warren . J.. Rose . K. L.. Carlucci . F.. Wang . Y.. Walport . M. J.. Mark Walport. Cook . H. T.. Botto . M.. 10.1073/pnas.0601094103. Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proceedings of the National Academy of Sciences. 103. 25. 9649–9654. 2006. 16769899. 1476693. 2006PNAS..103.9649P. free.
  19. Brown . J. S.. Hussell . T.. Gilliland . S. M.. Holden . D. W.. Paton . J. C.. Ehrenstein . M. R.. Walport . M. J.. Mark Walport. Botto . M.. 10.1073/pnas.012669199. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proceedings of the National Academy of Sciences. 99. 26. 16969–16974. 2002. 12477926. 139253. 2002PNAS...9916969B. free.
  20. 10.1073/pnas.89.11.4957. Botto . M.. Fong . K. Y.. So . A. K.. Barlow . R.. Routier . R.. Morley . B. J.. Walport . M. J.. Mark Walport. Homozygous hereditary C3 deficiency due to a partial gene deletion. Proceedings of the National Academy of Sciences of the United States of America. 89. 11. 4957–4961. 1992. 1350678. 49207. 1992PNAS...89.4957B . free .
  21. Taylor . P. R. . Carugati . A. . Fadok . V. A. . Cook . H. T. . Andrews . M. . Carroll . M. C. . Savill . J. S. . John Savill. Henson . P. M. . Botto . M. . 10.1084/jem.192.3.359 . Walport . M. J. . A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo . Journal of Experimental Medicine . 192 . 3 . 359–366 . 2000 . 10934224. 2193213 .
  22. Sir Mark Walport will lead UK Research and Innovation . www.gov.uk. en . 2 February 2017. 4 July 2017.
  23. RSE Welcomes 60 New Fellows. 15 February 2017 . . 28 March 2017.
  24. Web site: Sir Mark Walport . Royal Society. Anon. 2011 . 5 July 2012. One or more of the preceding sentences incorporates text from the royalsociety.org website where:

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Mark Walport".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.